Literature DB >> 2173670

Demonstration of quinolone phototoxicity in vitro.

B Przybilla1, A Georgii, T Bergner, J Ring.   

Abstract

The 'first-generation' quinolones cinoxacin, nalidixic acid, oxolinic acid, pipemidic acid and rosoxacin and the newly developed quinolones ciprofloxacin, enoxacin, fleroxacin, norfloxacin and ofloxacin were screened in vitro at 10(-5), 10(-4) and 10(-3) M concentrations for ultraviolet (UV)-induced phototoxic effects in a photohemolysis test. At 10(-3) M, photodependent effects of norfloxacin could not be evaluated, as hemolysis occurred without irradiation. All other compounds with the exception of ciprofloxacin were found to be phototoxic at 10(-3) M and some also at 10(-4) M. Hemolysis was UV dose dependent and for all compounds most prominent after exposure to UVA-rich radiation except for fleroxacin which was most active in the UVB range. Besides fleroxacin, also oxolinic acid, pipemidic acid and rosoxacin induced hemolysis with irradiations rich in UVB. It is concluded that quinolones have to be regarded as potentially phototoxic substances. Therefore intense light exposure should be avoided during treatment with these agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173670     DOI: 10.1159/000247894

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  4 in total

1.  Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances.

Authors:  Satomi Onoue; Yoshiko Tsuda
Journal:  Pharm Res       Date:  2006-11-30       Impact factor: 4.200

2.  Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones.

Authors:  Yoshiki Seto; Ryo Inoue; Masanori Ochi; Graham Gandy; Shizuo Yamada; Satomi Onoue
Journal:  AAPS J       Date:  2011-07-08       Impact factor: 4.009

3.  Spectral-luminescent properties and molecular orbital treatment of some mono- and difluoroquinolones.

Authors:  Anna V Polishchuk; Emilya T Karaseva; Tatyna B Emelina; Oanna Cramariuc; Vladimir E Karasev
Journal:  J Fluoresc       Date:  2011-01-13       Impact factor: 2.217

Review 4.  Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Authors:  J A Balfour; P A Todd; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.